skip to Main Content
Rafarma is a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, vaccines and specialty Pharma products in Europe & Asia. (307) 429-2029 Call info@rafarma.net Email

Rafarma Embarks on Aggressive Global Partnerships Plan

Nicosia, Cyprus, March 04, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its newly formulated strategies for aggressive global growth in 2021/2022. Given Rafarma’s current market position and the regulatory arena for the circulation of medicinal drugs in…

Read More

Letter To Shareholders from Chairman Ilya Shpurov

Nicosia, Cyprus, Nov. 09, 2020 (GLOBE NEWSWIRE) -- November 9, 2020 (GLOBE NEWSWIRE) Rafarma Pharmaceuticals, Inc. OTC:(RAFA) shares the following letter to shareholders from Chairman Ilya Shpurov: “It is my pleasure to provide the following update on Rafarma’s exciting future that should…

Read More

Rafarma Closes Biocogency Merger

Nicosia, Cyprus, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has closed the merger with BIOCOGENCY LABORATORIES. The new consolidated financials will include Slavich (http://www.slavich.ru), Slavich Trading House, and related companies based in Spain, Ireland,…

Read More

Rafarma Adds Prestigious New Board Chairman Ilia Shpurov

Ljubljana, Slovenia, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce the appointment of Ilia Shpurov as Chairman of the Board. Mr. Shpurov has a long history of technological developments, patents, and entrepreneurial achievements in biotech. Most…

Read More

Rafarma Inks Deal For CBD-Infused Drink Product

Ljubljana, Slovenia, June 22, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce the finalization of the agreement with Destination Marketing Group Co. Ltd. Thailand. Under the agreement, Destination Marketing will provide outsourcing services for the production of CBD-infused…

Read More
Back To Top